Aziyo Biologics: Funding, Investors & Team (Sep 2026)
Aziyo Biologics is a fully integrated, commercially oriented regenerative medicine company. Since its founding in 2015 the Company has expanded through acquisitions and strategic partnerships, creating a high growth commercial entity. Its proprietary products are used in orthopedic, cardiovascular and other medical specialties.
Aziyo Biologics has raised $18.0M across 2 funding rounds on record, the most recent an undisclosed round of $4.0M announced in Dec 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Aziyo Biologics Company Profile and Key Stats
Latest funding round on record: Dec 2022.
Aziyo Biologics Funding Rounds
Aziyo Biologics raised $14.0M in a Post-IPO Equity announced in Dec 2021.
1 years later, an undisclosed round of $4.0M was announced in Dec 2022.
Aziyo Biologics Founders and Leadership Team
No contact details are on record for this team yet.
Aziyo Biologics Funding Compared to Other Biotechnology Startups
Aziyo Biologics' latest round of $4.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Aziyo Biologics in Biotechnology and Silver Spring
Companies Similar to Aziyo Biologics
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Aziyo Biologics Funding FAQs
What does Aziyo Biologics do?
Aziyo Biologics is a fully integrated, commercially oriented regenerative medicine company. Since its founding in 2015 the Company has expanded through acquisitions and strategic partnerships, creating a high growth commercial entity. Its proprietary products are used in orthopedic, cardiovascular and other medical specialties.
How much funding has Aziyo Biologics raised?
Aziyo Biologics has raised $18.0M across 2 rounds on record. The most recent is an undisclosed round of $4.0M announced in Dec 2022.
When did Aziyo Biologics last raise funding?
Aziyo Biologics' most recent funding round on record is an undisclosed round of $4.0M, announced in Dec 2022.
Who is the CEO of Aziyo Biologics?
C Randal Mills is listed as CEO at Aziyo Biologics.
Where is Aziyo Biologics headquartered?
Aziyo Biologics is based in Silver Spring, Maryland, United States.
How many employees does Aziyo Biologics have?
Aziyo Biologics is in the 101-250 employee band.
How does Aziyo Biologics' funding compare to other Biotechnology startups?
Aziyo Biologics' latest round of $4.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Aziyo Biologics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Aziyo Biologics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.